1070473

Michael E. Thase, M.D. — FEI 3014568204

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 18, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Philadelphia, PA (United States)

Additional Details

Clinical Investigator (CI)